Innovative Tools for Digital Pathology: Automated ROI Detection and Image Patch Extraction
Read more
Regulatory Services
With the regulatory environment rapidly evolving, many organizations struggle to stay compliant. Our experts can guide you through the complex regulatory landscape necessary for successful clinical trials, product development, and market access. We help clients navigate critical critical regulatory requirements such as HIPAA, IVDR, and GxP.
Service overview
In both research and clinical settings, navigating the regulatory landscape can be daunting. The rapid evolution of rules and requirements often leaves teams feeling overwhelmed and uncertain about compliance, creating significant barriers to launching new solutions. This lack of confidence can lead to costly project delays and hesitance to pursue innovative research. Furthermore, many organizations struggle with the specialized expertise required to interpret and implement complex regulations, increasing the risk of non-compliance and project failure.
While the constantly shifting regulatory environment can create confusion and delays, it also opens the door for agile organizations to stand out. By proactively addressing these challenges, they can accelerate timelines and secure first-mover advantage in competitive markets.
Organizations that invest in regulatory knowledge and expertise not only mitigate compliance risks but also set the stage for strategic innovation. By overcoming roadblocks swiftly, they reduce project setbacks and unlock new possibilities for growth and impact.
At Velsera we understand these challenges, but also see the opportunity. Our experts specialize in navigating the complex regulatory landscape to help you conduct clinical trials and launch new products successfully. With a proven track record of assisting clients in complying with FDA guidelines, EMA requirements, and ICH standards, we empower organizations to move forward confidently.
Our expert regulatory team can provide you with tailored support - Whether you're developing a new diagnostic medical device or enhancing existing solutions. Our team has in-depth knowledge of the regulatory landscape, enabling us to guide you through the requirements necessary for compliance with FDA and EMA regulations, such as HIPAA and GDPR. This expertise ensures you meet all necessary benchmarks to facilitate a smooth approval process.
Why use Velsera’s Regulatory services
Better
Velsera’s team of regulatory experts offer comprehensive, up-to-date guidance designed to address your unique challenges. With our help, you can confidently tackle compliance requirements and stay focused on advancing innovation.
Faster
Navigating the regulatory landscape can be daunting and time-consuming. Velsera provides real-time insights and expert strategies, accelerating your path to compliance while minimizing disruptions to your core research activities.
Simpler
Velsera bridges the divide between groundbreaking research and regulatory compliance. We deliver tailored guidance to simplify complex processes, ensuring you stay ahead in an ever-evolving landscape.
Who we help accelerate
Clinical Diagnostic Laboratories
Grow revenue by expanding your NGS business. Velsera helps diagnostic labs rapidly establish and grow new, profitable NGS revenue streams. With our support, we can help your lab get up-and-running with an existing on-market assay (20+ LDT & IVD options available), including support for validation, revenue cycle management, and our Clinical Genomics Workspace (CGW) software to aid clinical decision-making.
NGS Assay & Equipment Manufacturers
Have you got a promising diagnostic test in development? Or do you have novel equipment that you want to drive uptake of in the clinical setting? Velsera can partner with you to bring new, promising tests to market by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, we can help your future laboratory customers with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake from customers. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.
Biotech & Pharma
Don’t wait until the last minute to design and develop your Companion Diagnostic (CDx) – it literally is the rate limiting gate keeper to scaling your new therapy! Velsera can partner with you to design and develop your test by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, once live in the market, we can help labs with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake from customers. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.
Solutions
Clinical Interpretation & Reporting
Grow revenue by expanding your NGS business. Velsera helps diagnostic labs rapidly establish and grow new, profitable NGS revenue streams. With our support, we can help your lab get up-and-running with an existing on-market assay (20+ LDT & IVD options available), including support for validation, revenue cycle management, and our Clinical Genomics Workspace (CGW) software to aid clinical decision-making.
NGS Assay Development & Expansion
Has your lab recognized an unmet need in the market? Velsera helps ambitious diagnostic labs generate revenue by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, we help with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.
IVD Compliance Transition
Don’t let compliance challenges impede your progress. Velsera assists labs in navigating the FDA clearance process for both new assays and existing Laboratory Developed Tests (LDTs). We provide the necessary “dry-lab” component for approved products, along with optional tertiary reporting to enhance your workflow.
Companion diagnostic development & scaling
Don’t wait until the last minute to design and develop your Companion Diagnostic (CDx) – it literally is the rate limiting gate keeper to scaling your new therapy! Velsera can partner with you to design and develop your test by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, once live in the market, we can help labs with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake from customers. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.
Real-world impact, trusted partnerships
“Velsera has been a great partner enabling our NGS offering so we can improve the quality and speed of patient care. With Velsera's team and technology, we have been able to streamline our workflow and customize our clinical report. We can run various assays using the single Velsera platform. And our physicians are highly complementary of the report we created with Velsera given the content and aesthetic.”
Blog
On December 12, 2024 | By Jovan Babic
Read more
Blog
On October 29, 2024 | By Christopher Wilkinson
Read more
Blog
On October 10, 2024 | By Cates Mallaney
Read more
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
Read more
Discover how our tailored solutions can elevate your operations by requesting a demo.